Trial Profile
Open-Label Clinical Study to Evaluate the Pharmacokinetics and Safety of AGM-130 after intravenous microdosing in Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 31 May 2017
Price :
$35
*
At a glance
- Drugs AGM-130 (Primary)
- Indications Breast cancer
- Focus First in man; Pharmacokinetics
- Sponsors AnyGen
- 15 Mar 2017 New trial record